APPLIED GENETIC TECHNOLOGIES CORP Accounts Receivable, Credit Loss Expense (Reversal)
APPLIED GENETIC TECHNOLOGIES CORP reported Accounts Receivable, Credit Loss Expense (Reversal) of -$358.00 thousand for the 12-month period ending 2019-06-30, per its 10-K filed 2020-09-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2020-09-18
- APPLIED GENETIC TECHNOLOGIES CORP accounts receivable, credit loss expense (reversal) for the quarter ending 2019-06-30 was -$100.00K, a 1766.67% decline year-over-year.
- APPLIED GENETIC TECHNOLOGIES CORP accounts receivable, credit loss expense (reversal) for the quarter ending 2019-03-31 was $0.00.
- APPLIED GENETIC TECHNOLOGIES CORP accounts receivable, credit loss expense (reversal) for the quarter ending 2018-12-31 was $111.00K.
- APPLIED GENETIC TECHNOLOGIES CORP accounts receivable, credit loss expense (reversal) for the quarter ending 2018-09-30 was -$369.00K.
- APPLIED GENETIC TECHNOLOGIES CORP accounts receivable, credit loss expense (reversal) for fiscal 2019 was -$358.00K, a 195.47% decline from fiscal 2018.
- APPLIED GENETIC TECHNOLOGIES CORP accounts receivable, credit loss expense (reversal) for fiscal 2018 was $375.00K.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|---|---|---|
| 2019-06-30 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-18 | -$100.00K derived: sum of 2 quarters · filed 2020-09-18 | $11.00K derived: sum of 3 quarters · filed 2020-09-18 | -$358.00K 10-K · filed 2020-09-18 |
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-13 | $111.00K derived: sum of 2 quarters · filed 2020-05-13 | -$258.00K 10-Q · filed 2020-05-13 | -$252.00K derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $111.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-05 | -$258.00K 10-Q · filed 2020-02-05 | -$252.00K derived: sum of 3 quarters · filed 2020-02-05 | |
| 2018-09-30 | -$369.00K 10-Q · filed 2019-11-12 | -$363.00K derived: sum of 2 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | $375.00K 10-K · filed 2019-09-26 | ||
| 2018-03-31 | $369.00K 10-Q · filed 2019-05-07 |